[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2012DN00845A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00845A
IN2012DN00845A IN845DEN2012A IN2012DN00845A IN 2012DN00845 A IN2012DN00845 A IN 2012DN00845A IN 845DEN2012 A IN845DEN2012 A IN 845DEN2012A IN 2012DN00845 A IN2012DN00845 A IN 2012DN00845A
Authority
IN
India
Prior art keywords
adhesive layer
directed
release liner
layer
backing layer
Prior art date
Application number
Other languages
English (en)
Inventor
Russell Adam Baird
Brad L Barnett
Russell D Beste
Original Assignee
Mylan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Inc filed Critical Mylan Inc
Publication of IN2012DN00845A publication Critical patent/IN2012DN00845A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J123/00—Adhesives based on homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Adhesives based on derivatives of such polymers
    • C09J123/02—Adhesives based on homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Adhesives based on derivatives of such polymers not modified by chemical after-treatment
    • C09J123/18—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms
    • C09J123/20—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms having four to nine carbon atoms
    • C09J123/22—Copolymers of isobutene; Butyl rubber ; Homo- or copolymers of other iso-olefines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/18—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms
    • C08L23/20—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms having four to nine carbon atoms
    • C08L23/22—Copolymers of isobutene; Butyl rubber; Homopolymers or copolymers of other iso-olefins
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00—Polymer mixtures characterised by other features
    • C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/02—Organic macromolecular compounds, natural resins, waxes or and bituminous materials
    • C08L2666/04—Macromolecular compounds according to groups C08L7/00 - C08L49/00, or C08L55/00 - C08L57/00; Derivatives thereof
    • C08L2666/06—Homopolymers or copolymers of unsaturated hydrocarbons; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Adhesives Or Adhesive Processes (AREA)
IN845DEN2012 2009-07-21 2010-07-19 IN2012DN00845A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27139809P 2009-07-21 2009-07-21
PCT/US2010/042428 WO2011011318A1 (fr) 2009-07-21 2010-07-19 Procédé de fabrication en continu d'un tampon transdermique à base de polyisobutylène

Publications (1)

Publication Number Publication Date
IN2012DN00845A true IN2012DN00845A (fr) 2015-06-26

Family

ID=42813466

Family Applications (1)

Application Number Title Priority Date Filing Date
IN845DEN2012 IN2012DN00845A (fr) 2009-07-21 2010-07-19

Country Status (13)

Country Link
US (2) US10632082B2 (fr)
EP (1) EP2456839A1 (fr)
JP (1) JP5887269B2 (fr)
KR (1) KR101738650B1 (fr)
CN (1) CN102597149A (fr)
AU (1) AU2010276456B2 (fr)
BR (1) BR112012001349B8 (fr)
CA (1) CA2768646C (fr)
IN (1) IN2012DN00845A (fr)
MX (1) MX2012000947A (fr)
NZ (1) NZ597993A (fr)
RU (1) RU2541577C2 (fr)
WO (1) WO2011011318A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN00845A (fr) * 2009-07-21 2015-06-26 Mylan Inc
AU2010301154B2 (en) * 2009-09-30 2016-02-25 Molnlycke Health Care Ab A method of attaching grip tabs to the carrier layer of a film dressing
US20110200663A1 (en) * 2010-02-12 2011-08-18 Nitto Denko Corporation Methylphenidate patch preparation
JP2012067291A (ja) * 2010-08-27 2012-04-05 Nitto Denko Corp 非水系電池用粘着テープ
EP2599478A1 (fr) 2011-11-30 2013-06-05 Acino AG Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
US20130184351A1 (en) * 2011-12-21 2013-07-18 Jar Laboratories Lidocaine patch and methods of use thereof
US9072682B2 (en) 2012-12-31 2015-07-07 Mylan Inc. Transdermal dosage form for low-melting point active agent
WO2015059638A2 (fr) * 2013-10-21 2015-04-30 Florida State University Research Foundation Combinaison du stimulant de snc et d'antagoniste de récepteur d'opioïdes comme traitement anti-obésité non addictif, non aversif et synergique
US10759076B2 (en) 2014-07-04 2020-09-01 Luye Pharma Ag Device for the manufacture of pharmaceutical patches
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
WO2018155682A1 (fr) * 2017-02-27 2018-08-30 帝國製薬株式会社 Préparation transdermique contenant de la rivastigmine
USD999385S1 (en) 2021-10-18 2023-09-19 Dbv Technologies Patch assembly
USD999384S1 (en) 2021-10-18 2023-09-19 Dbv Technologies Patch assembly

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US736992A (en) * 1902-08-16 1903-08-25 William E Messacar Combined awning and window-shade.
US3634381A (en) * 1968-04-27 1972-01-11 Basf Ag Degradation of high molecular weight polyisobutylene in extruders
JPS591180B2 (ja) 1978-11-07 1984-01-10 東燃石油化学株式会社 コ−トハンガ−ダイ
US4559222A (en) 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems
US5508038A (en) 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
CA2075517C (fr) 1992-04-01 1997-03-11 John Wick Piece transdermique incorporant une pellicule de polymeres incorporee a l'aide d'un agent actif
US5704555A (en) * 1993-08-02 1998-01-06 Illinois Institute Of Technology Single-screw extruder for solid state shear extrusion pulverization and method
JPH0873694A (ja) 1994-09-02 1996-03-19 Mitsubishi Chem Corp 塗装性樹脂組成物成形体
US6248378B1 (en) * 1998-12-16 2001-06-19 Universidad De Sevilla Enhanced food products
US6365178B1 (en) 1996-09-06 2002-04-02 Watson Pharmaceuticals, Inc. Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
US5830811A (en) * 1997-03-18 1998-11-03 Alliedsignal Inc. Load leveling yarns and webbings
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10001546A1 (de) * 2000-01-14 2001-07-19 Beiersdorf Ag Verfahren zur kontinuierlichen Herstellung und Beschichtung von Selbstlebemassen auf Basis von Polyisobutylen mit mindestens einem pharmazeutischen Wirkstoff
EP1591122B1 (fr) * 2000-06-20 2012-09-26 Novartis AG Méthode pour l'administration de biphosphonates
DE10056010A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Pflaster mit hautpflegenden Substanzen
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
CN100542533C (zh) * 2004-08-12 2009-09-23 日东电工株式会社 包含芬太尼的粘合剂制剂
IN2012DN00845A (fr) * 2009-07-21 2015-06-26 Mylan Inc

Also Published As

Publication number Publication date
BR112012001349A2 (pt) 2017-07-11
US10632082B2 (en) 2020-04-28
WO2011011318A8 (fr) 2011-08-18
KR101738650B1 (ko) 2017-05-22
US11911522B2 (en) 2024-02-27
RU2541577C2 (ru) 2015-02-20
CN102597149A (zh) 2012-07-18
US20110020426A1 (en) 2011-01-27
RU2012106117A (ru) 2013-08-27
AU2010276456A1 (en) 2012-03-01
BR112012001349B1 (pt) 2020-10-27
CA2768646A1 (fr) 2011-01-27
AU2010276456B2 (en) 2014-07-03
MX2012000947A (es) 2012-02-29
KR20120056830A (ko) 2012-06-04
JP2012533632A (ja) 2012-12-27
NZ597993A (en) 2013-06-28
US20200253886A1 (en) 2020-08-13
WO2011011318A1 (fr) 2011-01-27
JP5887269B2 (ja) 2016-03-16
EP2456839A1 (fr) 2012-05-30
CA2768646C (fr) 2014-07-08
BR112012001349B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
IN2012DN00845A (fr)
MX2010002452A (es) Sistema de entrega de medicamento transdermico que comprende una capa de liberacion recubierta.
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
WO2008090555A3 (fr) Dispositifs médicaux dotés d'une matrice adhérant à ceux-ci
MX345777B (es) Formulaciones de tabletas bicapa.
MX336497B (es) Compuestos de tetrahidro-pirido-piridina y tetrahidro-pirido-pirim idina y su uso como moduladores de los receptores de c5a.
NZ605352A (en) Process for producing glycosaminoglycans
AU2012259422A8 (en) Solid forms of a pharmaceutically active substance
WO2012072256A3 (fr) Formulation de lacosamide en prise quotidienne unique
IL210561A (en) Production items that release an active ingredient, a method of making and using them
WO2008133982A3 (fr) Timbre adhésif contenant un agent aversif
EP2617793A4 (fr) Composé adhésif autocollant, bande adhésive autocollante, et procédé de traitement de tranche
MX2013008737A (es) Formas de dosificacion oral para tasocitinib que comprende liberacion modificada.
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
NZ594214A (en) Tablets comprising cobicistat, elvitegravir, emtricitabine and tenofovir disoproxil fumarate for combination therapy
MX2011011829A (es) Composicion para suministro sostenido de farmaco que comprende un aglutinante geopolimerico.
TN2012000279A1 (en) Processes for the manufacture of a pharmaceutically active agent
IN2012DN01225A (fr)
NZ592359A (en) Transdermal delivery device and method
AR082595A1 (es) Aplicador de dosis unica y metodo
WO2010130773A3 (fr) Dérivés de benzoxazolone en tant qu'inhibiteurs d'aldostérone synthase
NZ709521A (en) Transdermal dosage form for low-melting point active agent
MX353623B (es) Sistema de suministro de farmaco.
TW201129347A (en) Packaged medical adhesive composite and method of delivering the composite
WO2008058220A3 (fr) Système de libération de médicament transdermique